Psychometric analysis in support of shortening the Scale for the Assessment of Negative Symptoms

European Neuropsychopharmacology

Volumn 23, Issue 9, 2013, Pages 1051-1056

  Levine, Stephen Z ^a   Leucht, Stefan ^b  

^a UNIVERSITY OF HAIFA   (Israel)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Clinical trial; Predominant negative symptoms; Psychometrics; Scale for the Assessment of Negative Symptoms; Schizophrenia; Symptom severity

Indexed keywords

AMISULPRIDE; PLACEBO;

ADULT; ANTISOCIAL BEHAVIOR; ARTICLE; ATTENTION DEFICIT DISORDER; COMPARATIVE STUDY; DATA ANALYSIS; DIAGNOSTIC VALUE; FACTORIAL ANALYSIS; FEASIBILITY STUDY; HUMAN; MOOD DISORDER; MULTICENTER STUDY (TOPIC); NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOM; SCHIZOPHRENIA; TREATMENT DURATION; TREATMENT RESPONSE; VALIDITY;

CLINICAL TRIAL; PREDOMINANT NEGATIVE SYMPTOMS; PSYCHOMETRICS; SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS; SCHIZOPHRENIA; SYMPTOM SEVERITY;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84884207775     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.11.008     Document Type: Article

References (40)

1. Alphs L. An industry perspective on the NIMH consensus statement on negative symptoms. Schizophr. Bull. 2006, 32:225-230.
2. Andreasen N.C. Scale for the Assessment of Negative Symptoms 1983, University of Iowa, Iowa City.
3. Andreasen N.C., Arndt S., Alliger R., Miller D., Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch. Gen. Psychiatry 1995, 52:341-351.
4. Baker F. The Basics of Item Response Theory 2001, ERIC Clearinghouse on Assessment and Evaluation, University of Maryland College Park, MD.
5. Bowie C.R., Reichenberg A., Patterson T.L., Heaton R.K., Harvey P.D. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am. J. Psychiatry 2006, 163:418-425.
6. Boyer P., Lecrubier Y., Puech A.J., Dewailly J., Aubin F. Treatment of negative symptoms in schizophrenia with amisulpride. Br. J. Psychiatry 1995, 166:68-72.
7. Cella D., Yount S., Rothrock N., Gershon R., Cook K., Reeve B., Ader D., Fries J.F., Bruce B., Rose M. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med. Care 2007, 45:S3-S11.
8. Cole J.C., Rabin A.S., Smith T.L., Kaufman A.S. Development and validation of a Rasch-derived CES-D short form. Psychol. Assess. 2004, 16:360-372.
9. Danion J.M., Rein W., Fleurot O. Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group. Am. J. Psychiatry 1999, 156:610-616.
10. Elvevag B., Storms G. Scaling and clustering in the study of semantic disruptions in patients with schizophrenia: a re-evaluation. Schizophr. Res. 2003, 63:237-246.
11. Embretson S.E., Reise S.P. Item Response Theory for Psychologists 2000, Lawrence Erlbaum Associates, Mahwah, NJ.
12. Garcia S.F., Cella D., Clauser S.B., Flynn K.E., Lad T., Lai J.S., Reeve B.B., Smith A.W., Stone A.A., Weinfurt K. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J. Clin. Oncol. 2007, 25:5106-5112.
13. Gorsuch R.L. Factor Analysis 1993, Lawrence Erlbaum Associates, New Jersey.
14. Harvey P.D., Koren D., Reichenberg A., Bowie C.R. Negative symptoms and cognitive deficits: what is the nature of their relationship?. Schizophr. Bull. 2006, 32:250-258.
15. Hu L.T., Bentler P.M. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct. Equation Model. 1999, 6:1-55.
16. Jöreskog K.G., Sörbom D. LISREL 8: Structural Equation Modeling with the SIMPLIS Command Language 1993, Scientific Software, Chicago.
17. Keefe R.S., Harvey P.D., Lenzenweger M.F., Davidson M., Apter S.H., Schmeidler J., Mohs R.C., Davis K.L. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Res. 1992, 44:153-165.
18. Kelley M.E., van Kammen D.P., Allen D.N. Empirical validation of primary negative symptoms: independence from effects of medication and psychosis. Am. J. Psychiatry 1999, 156:406-411.
19. Khan A., Lewis C., Lindenmayer J.P. Use of NON-PARAMETRIC Item Response Theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS). BMC Psychiatry 2011, 11:178.
20. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32:214-219.
21. Kirkpatrick B., Fischer B. Subdomains within the negative symptoms of schizophrenia: commentary. Schizophr. Bull. 2006, 32:246-249.
22. Kline P. The Handbook of Psychological Testing 1993, Routledge, London.
23. Kraepelin E. Dementia Praecox and Paraphrenia (R.M. Barclay, Trans.) 1919, RE Krieger, Huntingdon, NY.
24. Kruskal J.B., Wish M. Multidimensional Scaling 1978, Sage, Newbury, CA.
25. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373:31-41.
26. Levine S.Z., Rabinowitz J., Rizopoulos D. Recommendations to improve the positive and negative syndrome scale (PANSS) based on item response theory. Psychiatry Res. 2011, 188:446-452.
27. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., Hsiao J.K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 2005, 353:1209-1223.
28. Loo H., Poirier-Littre M.F., Theron M., Rein W., Fleurot O. Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia. Br. J. Psychiatry 1997, 170:18-22.
29. Marder S.R., Daniel D.G., Alphs L., Awad A.G., Keefe R.S. Methodological issues in negative symptom trials. Schizophr. Bull. 2011, 37:250-254.
30. Mueser K.T., Sayers S.L., Schooler N.R., Mance R.M., Haas G.L. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms. Am. J. Psychiatry 1994, 151:1453-1462.
31. Nunnally J.C., Bernstein I.H. Psychometric Theory 1978, McGraw-Hill, London.
32. Peralta V., Cuesta M.J., de Leon J. Positive and negative symptoms/syndromes in schizophrenia: reliability and validity of different diagnostic systems. Psychol. Med. 1995, 25:43-50.
33. Rabany L., Weiser M., Werbeloff N., Levkovitz Y. Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS. Schizophr. Res. 2011, 126:226-230.
34. Reeve B.B., Hays R.D., Bjorner J.B., Cook K.F., Crane P.K., Teresi J.A., Thissen D., Revicki D.A., Weiss D.J., Hambleton R.K., Liu H., Gershon R., Reise S.P., Lai J.S., Cella D. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med. Care 2007, 45:S22-S31.
35. Reise S.P., Henson J.M. A discussion of modern versus traditional psychometrics as applied to personality assessment scales. J. Pers. Assess. 2003, 81:93-103.
36. Rizopoulos D. ltm: an R package for latent variable modelling and item response theory analyses. J Stat. Software 2006, 17:1-25.
37. Samejima F. Estimation of latent ability using a response pattern of graded scores. Psychometr. Mon. Suppl. 1969, 100-114.
38. Santor D.A., Ascher-Svanum H., Lindenmayer J.P., Obenchain R.L. Item response analysis of the Positive and Negative Syndrome Scale. BMC Psychiatry 2007, 7:66.
39. Sayers S.L., Curran P.J., Mueser K.T. Factor structure and construct validity of the scale for the assessment of negative symptoms. Psychol. Assess. 1996, 8:269-280.
40. Teresi J.A., Fleishman J.A. Differential item functioning and health assessment. Qual. Life Res. 2007, 16(1):33-42.